Jefferies Reiterates Buy on Amgen (AMGN) Following FDA Approval of Humira Biosimilar

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. META
4. VRTX
5. LGND
6. ONON
7. USO
8. PSKY
9. ARAI
10. MA

Go back to Jefferies Reiterates Buy on Amgen (AMGN) Following FDA Approval of Humira Biosimilar
Amgen Inc (NASDAQ: AMGN) Delayed: 412.65 +19.49 (4.96%)
Previous Close $393.16    52 Week High $176.85 
Open $405.25    52 Week Low $133.64 
Day High $413.00    P/E 62.15 
Day Low $398.52    EPS $6.64 
Volume 1,467,031